Day One Biopharmaceuticals's total assets for Q3 2024 were $600.81M, an increase of 50.04% from the previous quarter. DAWN total liabilities were $45.34M for the fiscal quarter, a -51.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.